|
|
Volumn 9, Issue 3, 2000, Pages 529-542
|
|
Novel immunomodulators for topical skin disease therapy
|
|
Author keywords
ABT 281; Arachidonic acid; Atopic dermatitis; Clinical trials; Corticosteroids; Cyclooxygenase; Cyclosporin; Eicosanoids; ICI 204 219; Lipoxygenase; Phospholipase A2; Platelet activating factor; Psoriasis; SDM ASM 281 240; SDM ASM 981; Tacrolimus; Zileuton
|
|
Indexed keywords
3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 (2 QUINOLINYLMETHOXY) 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID;
ANTIHISTAMINIC AGENT;
ANTIINFLAMMATORY AGENT;
ARACHIDONIC ACID;
ASCOMYCIN;
CORTICOSTEROID;
CYCLOSPORIN A;
ICOSANOID;
IMMUNOMODULATING AGENT;
IMMUNOSUPPRESSIVE AGENT;
MACROLIDE;
METHOTREXATE;
MONTELUKAST;
PHOSPHOLIPASE A2;
PHOSPHOLIPASE A2 INHIBITOR;
SDM ASM 281 240;
SDM ASM 981;
TACROLIMUS;
THROMBOCYTE ACTIVATING FACTOR;
UNCLASSIFIED DRUG;
ZAFIRLUKAST;
ZILEUTON;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIINFLAMMATORY ACTIVITY;
ATOPIC DERMATITIS;
CONTACT DERMATITIS;
FOLLICULITIS;
HUMAN;
HYPERTRICHOSIS;
HYPOPIGMENTATION;
INFLAMMATION;
MEDIATOR RELEASE;
NONHUMAN;
PSORIASIS;
PURPURA;
REVIEW;
ROSACEA;
SKIN ATROPHY;
TELANGIECTASIA;
|
|
EID: 0033993542
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.3.529 Document Type: Review |
|
Times cited : (11)
|
|
References (101)
|
